ShangBay Capital
William Dai has more than 20 years of experience in corporate finance, mergers and acquisitions, and capital markets in both China and the U.S. He has held senior executive roles at major U.S. multinational companies. In those roles, William was responsible for the overall execution and was held accountable to the highest ethical standards in his business dealings.
He is well-respected among financial and investment circles, and is a recognized leader in the industry. In addition, due to his hands-on experience leading multiple large international medical device companies, he has a very in-depth knowledge of the medical device industry and its market dynamics.
William Dai holds a master’s degree in business administration with an emphasis on finance from Michigan State University.
ShangBay Capital
ShangBay Capital is a venture capital company that brings both U.S. and Chinese investors access to best-in-class investments in the U.S. medical devices technology, biotechnology, and mobile healthcare sectors through early-stage venture equity participation.